Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing MCI can be a long and difficult process, especially in rural areas where access to licensed neuropsychologists is limited.

To increase accessibility to cognitive assessments, a team of researchers at the University of Missouri created a portable system to efficiently measure multiple aspects of motor function. The device is simple and affordable, combining a depth camera, a force plate and an interface board.

The interdisciplinary team of Mizzou researchers includes Trent Guess, an associate professor in the College of Health Sciences, Jamie Hall, an associate teaching professor in the College of Health Sciences, and Praveen Rao, an associate professor in the College of Engineering. In a recent study, the team examined older adults, some of whom had MCI, and asked them to complete three activities: standing still, walking and standing up from a bench. The catch? Participants had to complete these activities while counting backwards in intervals of seven at the same time.

Based off their performance, which was captured by the new portable system, the data was fed into a machine learning model - a type of artificial intelligence - that accurately identified 83% of those in the study with MCI.

"The areas of the brain involved in cognitive impairment overlap with areas of the brain involved in motor function, so when one is diminished, the other is impacted as well," said Guess. "These can be very subtle differences in motor function related to balance and walking that our new device is able to detect but would go unnoticed through observation."

With the number of Americans with Alzheimer’s disease expected to more than double by 2060 according to the Centers for Disease Control and Prevention, the portable device has the potential to help millions of older adults given that MCI is one of the precursors to Alzheimer's and dementia.

"Alzheimer’s disease is a significant problem here in the U.S. We know that if we can identify people early, we can provide early intervention to halt or slow the progression of the disease," Hall said. "Only about 8% of people in the U.S. who are believed to have MCI receive a clinical diagnosis."

Hall added the team’s long-term goal is get the new portable system into various settings such as county health departments, assisted living facilities, community centers, physical therapy clinics and senior centers to allow for more screenings.

"There are new drugs coming out to treat those with MCI, but you need a diagnosis of MCI to qualify for the medications," Hall said. "Our portable system can detect if a person walks slower or doesn’t take as big of a step because they are thinking very hard. Some people have more sway and are less balanced or are slower to stand up when they are sitting. Our technology can measure these subtle differences in a way that you could not with a stopwatch."

Guess will continue the research with additional participants and also look at the portable system’s ability to detect fall risk and frailty among older adults.

"This portable system has many other applications, too, including looking at those with concussions, sports rehabilitation, ALS and Parkinson’s disease, knee replacements and hip replacements," Guess said. "Moving is an important part of who we are. It’s rewarding to see that this portable system can be beneficial in a lot of different ways."

And those participating in the study are invested in the research, Hall added.

"Many of those who came in to be tested either have been diagnosed with MCI or have a family member who has Alzheimer’s disease, so they feel strongly about helping us move this forward," Hall said. "It really amplifies why this is so important to me."

Hall JB, Akter S, Rao P, Kiselica A, Ranum R, Thomas JM, Guess TM.
Feasibility of Using a Novel, Multimodal Motor Function Assessment Platform With Machine Learning to Identify Individuals With Mild Cognitive Impairment.
Alzheimer Dis Assoc Disord. 2024 Oct-Dec 01;38(4):344-350. doi: 10.1097/WAD.0000000000000646

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...